# The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients

> **NCT03809533** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Amit D Tevar, MD** · enrollment: 30 (actual)

## Conditions studied

- Kidney Transplantation
- Hepatitis C

## Interventions

- **DRUG:** sofosbuvir/velpatasvir

## Key facts

- **NCT ID:** NCT03809533
- **Lead sponsor:** Amit D Tevar, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-05-29
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809533, "The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03809533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*